Nah. Regulators have performance metrics same as everyone. They'll gleefully target 150 headcount biotech firms in a heartbeat if they think there's a win to be had and smaller firms generally dont have the legal war chest required to fight a complianceviolation beef. See Also: OIG going after United Therapeutics on light pretext.